The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

SOLV

Concerning the House

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

United States · www.solventum.com

The Long Run

FY 2024–2025 · 2 years

LineLatestCAGRTrend
Revenue$8.32B+2.4%
Gross profit$4.69B+0.0%
Operating income$1.04B-38.8%
Net income$479.00M-64.4%
Cash from ops$1.92B+61.6%
Quotation

$86.46

+1.17 (+1.4%)

52w hi$88.55
52w lo$62.49
Vol733.18K
As ofAug 13
The Verdict

Hold

Our score +0.13

Short-0.10
Medium+0.24
Long+0.37

computed 2026-08-13

By the Numbers

Solventum Corporation

Healthcare · Medical Instruments & Supplies

Market cap$14.72B
Enterprise value$19.41B
Trailing P/E10.57x
Forward P/E11.97x
EV / EBITDA17.04x
P / S (ttm)1.77x
Profit margin17.3%
Return on equity34.0%
Revenue growth+2.2%
Earnings growth+3.9%
Debt / equity110.31
Risk Metrics
Beta vs SPX0.88
Corr SPX0.46
Annual vol31.0%
Annual ret+25.2%
Sharpe0.81
Max DD-27.5%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.27
Sector+0.12
Technical+0.00
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$85.72$86.81$85.39$86.46733.18K
Aug 12$83.23$85.60$82.25$85.29834.00K
Aug 11$84.43$86.33$84.05580.69K
Aug 10$82.29$86.03$81.76$85.211.40M
Aug 7$81.95$83.69$81.22$82.981.10M